Working…
ClinicalTrials.gov
Help guide our efforts to modernize ClinicalTrials.gov.
Send us your comments by March 14, 2020.

Key Record Dates

ClinicalTrials.gov Identifier: NCT02406742
Brief Title: A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (ENHANCE)

First Submitted : March 30, 2015
First Submitted that Met QC Criteria : March 30, 2015
First Posted : April 2, 2015 (Estimate)

Last Update Submitted that Met QC Criteria : December 10, 2018
Last Update Posted : December 11, 2018